看通集團(01059.HK)中期純利升12.25%至688.4萬港元
格隆匯 2 月 25日丨看通集團(01059.HK)公佈中期業績,截至2020年12月31日止6個月,實現收益6699.3萬港元,同比減少13.49%;期內溢利688.4萬港元,同比增長12.25%;基本及經攤薄每股盈利0.03港仙;不派息。
公吿稱,收益減少主要由於回顧期內產品組合變動以及在該期間,因集團一直銷售的服務和產品的性質,在新冠肺炎疫情肆虐下,導致市場推廣活動縮減以及無法使用網絡促銷替代所致。
溢利的產生主要由於回顧期內其他收入的增加,並減少經常性開支及分銷成本及研究開發成本減少所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.